Senior Leadership at the UT Southwestern Simmons Cancer Center is comprised of the Director, Deputy Director, three Associate Directors representing basic, clinical and population research and the Associate Director for Administration. These leaders are responsible for collaborations across the scientific programs of the Center, direction and strategic planning, oversight of shared resources, education, and development of community outreach and budgetary oversight. Over the past four years. Dr. James Willson has provided vision and strong leadership as Director of UT Southwestern Simmons Cancer Center. Dr. Joan Schiller was appointed Deputy Director in 2006 and has led the development of the Center's disease oriented teams and an enabling clinical research infrastructure that has been integrated with the Medical Center's affiliated hospitals. Dr. Michael White serves as Associate Director for Basic Research and in this role has been instrumental in the development of the Center's basic research programs and the engagement of UT Southwestern cancer researchers into the Cancer Center. Dr. David Euhus serves as Associate Director for Clinical Research and in this role he is responsible for developing and maintaining a robust clinical trials enterprise for the Cancer Center and in partnership with the Deputy Director has responsibility for the oversight of the clinical trials support resources and the protocol review and monitoring system. Dr. Celette Sugg Skinner, who joined the Simmons Cancer Center in 2007, serves as Associate Director for Population Science. In this role she is leading the development of a research program in population science and cancer control and building interactions between basic and clinical faculty across the cancer control spectrum. This leadership team functions as a cohesive group that together has catalyzed new transdisciplinary collaborations and coordination that are transforming the cancer research environment at UT Southwestern.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA142543-03
Application #
8380759
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
3
Fiscal Year
2012
Total Cost
$627,764
Indirect Cost
$528,774
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Rashdan, Sawsan; Minna, John D; Gerber, David E (2018) Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy. Lancet Respir Med 6:472-478
Wijayatunge, Ranjula; Holmstrom, Sam R; Foley, Samantha B et al. (2018) Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis. Mol Cell Biol 38:
Hamann, Heidi A; Shen, Megan J; Thomas, Anna J et al. (2018) Development and Preliminary Psychometric Evaluation of a Patient-Reported Outcome Measure for Lung Cancer Stigma: The Lung Cancer Stigma Inventory (LCSI). Stigma Health 3:195-203
Miyata, Naoteru; Morris, Lindsey L; Chen, Qing et al. (2018) Microbial Sensing by Intestinal Myeloid Cells Controls Carcinogenesis and Epithelial Differentiation. Cell Rep 24:2342-2355
Mokdad, Ali A; Xie, Xian-Jin; Zhu, Hong et al. (2018) Statistical justification of expansion cohorts in phase 1 cancer trials. Cancer 124:3339-3345
Murphy, Caitlin C; Singal, Amit G; Baron, John A et al. (2018) Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase. Gastroenterology 155:1716-1719.e4
Barnes, Arti; Betts, Andrea C; Borton, Eric K et al. (2018) Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS 32:1861-1870
Murphy, Caitlin C; Fullington, Hannah M; Alvarez, Carlos A et al. (2018) Polypharmacy and patterns of prescription medication use among cancer survivors. Cancer 124:2850-2857
McMillan, Elizabeth A; Ryu, Myung-Jeom; Diep, Caroline H et al. (2018) Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. Cell 173:864-878.e29
Zhang, Shuyuan; Nguyen, Liem H; Zhou, Kejin et al. (2018) Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration. Gastroenterology 154:1421-1434

Showing the most recent 10 out of 501 publications